{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:45Z","timestamp":1786118805581,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/ico.0b013e31816f27ab","type":"journal-article","created":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T06:14:43Z","timestamp":1219299283000},"page":"930-934","source":"Crossref","is-referenced-by-count":29,"title":["Evaluation of Toxicity of Commercial Ophthalmic Fluoroquinolone Antibiotics as Assessed on Immortalized Corneal and Conjunctival Epithelial Cells"],"prefix":"10.1097","volume":"27","author":[{"given":"Alejandro Babay\u00e1n","family":"Sosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth P","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny A","family":"Asbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 2","key":"R1-15-20210204","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.survophthal.2004.01.005","article-title":"Fluoroquinolones: mechanism of action, classification and development of resistance.","volume":"49","author":"Blondeau","year":"2004","journal-title":"Surv Ophthalmol"},{"issue":"Suppl 2","key":"R2-15-20210204","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.survophthal.2004.01.004","article-title":"Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones.","volume":"49","author":"Hwang","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"R3-15-20210204","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0161-6420(99)00716-2","article-title":"Emerging fluoroquinolones resistance in bacterial keratitis. A 5-year review.","volume":"106","author":"Goldstein","year":"1999","journal-title":"Ophthalmology"},{"key":"R4-15-20210204","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)00196-8","article-title":"Emerging ciprofloxacin-resistant Pseudomonas aeruginosa.","volume":"128","author":"Chaudhry","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R5-15-20210204","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0161-6420(00)00179-2","article-title":"Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.","volume":"107","author":"Alexandrakis","year":"2000","journal-title":"Ophthalmology"},{"key":"R6-15-20210204","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00055735-200408000-00007","article-title":"Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections.","volume":"15","author":"Mah","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"R7-15-20210204","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0002-9394(00)00642-5","article-title":"Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis.","volume":"131","author":"Mallari","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R8-15-20210204","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2415-3-10","article-title":"Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea.","volume":"3","author":"Reviglio","year":"2003","journal-title":"BMC Ophthalmol"},{"key":"R9-15-20210204","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1600-0420.1995.tb00277.x","article-title":"Effects of antiglaucoma drugs on ocular surface.","volume":"73","author":"Yalvac","year":"1995","journal-title":"Acta Ophthalmol Scand"},{"key":"R10-15-20210204","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1442-9071.2000.00237.x","article-title":"Adverse effects of topical antiglaucoma drugs on the ocular surface.","volume":"28","author":"Arici","year":"2000","journal-title":"Clin Exp Ophthalmol"},{"key":"R11-15-20210204","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s004170100328","article-title":"Ocular surface changes induced by topical application of latanoprost and timolol: a short-term study in glaucomatous patients with and without allergic conjunctivitis.","volume":"239","author":"Costagliola","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R12-15-20210204","first-page":"234","article-title":"Quantitative cytotoxicity of preservatives evaluated in cell culture with Changs human conjunctival cell-effect of temperature on cytotoxicity.","volume":"26","author":"Takahashi","year":"1982","journal-title":"Jpn J Ophthalmol"},{"key":"R13-15-20210204","first-page":"642","article-title":"Quaternary ammoniums and other preservatives contribution in oxidative stress and apoptosis on Changs conjunctival cells.","volume":"42","author":"Debbasch","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-15-20210204","first-page":"948","article-title":"Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells.","volume":"42","author":"Geerling","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-15-20210204","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1442-9071.2004.00782.x","article-title":"Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro.","volume":"32","author":"Cha","year":"2004","journal-title":"Clin Exp Ophthalmol"},{"key":"R16-15-20210204","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000265175","article-title":"Cytotoxicity of mercurial preservatives in cell culture.","volume":"14","author":"Takahashi","year":"1982","journal-title":"Ophthalmic Res"},{"key":"R17-15-20210204","first-page":"1091","article-title":"Immortalized human corneal epithelial cells for ocular toxicity and inflammation studies.","volume":"40","author":"Offord","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-15-20210204","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/02713680490503787","article-title":"Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent.","volume":"28","author":"Ubels","year":"2004","journal-title":"Curr Eye Res"},{"key":"R19-15-20210204","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00003226-200405000-00015","article-title":"Development of a rabbit model of tear film instability and evaluation of viscosity of artificial tear preparations.","volume":"23","author":"Nakamura","year":"2004","journal-title":"Cornea"},{"key":"R20-15-20210204","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/cryo.2001.2324","article-title":"Desiccation tolerance in human cells.","volume":"42","author":"Puhlev","year":"2001","journal-title":"Cryobiology"},{"key":"R23-15-20210204","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ophtha.2004.09.029","article-title":"Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor.","volume":"112","author":"Solomon","year":"2005","journal-title":"Ophthalmology"},{"key":"R24-15-20210204","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0002-9394(03)00294-0","article-title":"Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.","volume":"136","author":"Kowalski","year":"2003","journal-title":"Am J Opththalmol"},{"key":"R25-15-20210204","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1542-0124(12)70120-9","article-title":"Effects of topical antiglaucoma medications on the ocular surface.","volume":"3","author":"Asbell","year":"2005","journal-title":"Ocul Surf"},{"key":"R26-15-20210204","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02853166","article-title":"Effects of common ophthalmic preservatives on ocular health.","volume":"18","author":"Noecker","year":"2001","journal-title":"Adv Ther"},{"key":"R27-15-20210204","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","article-title":"Corneal and conjunctival changes caused by commonly used glaucoma medications.","volume":"23","author":"Noecker","year":"2004","journal-title":"Cornea"},{"key":"R28-15-20210204","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0886-3350(00)00411-9","article-title":"Epithelial healing rates with topical ciprofloxacin, ofloxacin, and ofloxacin with artificial tears after photorefractive keratectomy.","volume":"26","author":"Patel","year":"2000","journal-title":"J Cataract Refract Surg"},{"issue":"Suppl","key":"R29-15-20210204","first-page":"4939","article-title":"Comparison of relative toxicity of four antibiotics using the human corneal epithelial cell culture system.","volume":"45","author":"Yee","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R30-15-20210204","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.ICL.00000117255.97190.98","article-title":"Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy.","volume":"30","author":"Kovoor","year":"2004","journal-title":"Eye Contact Lens"},{"key":"R31-15-20210204","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.icl.0000185041.08549.45","article-title":"Confocal assessment of the effects of fourth-generation fluoroquinolones on the cornea.","volume":"32","author":"Ly","year":"2006","journal-title":"Eye Contact Lens"},{"issue":"Suppl","key":"R32-15-20210204","first-page":"4909","article-title":"In vivo toxicity of preserved and self-preserved antibiotics in mouse corneal keratocytes.","volume":"46","author":"Baez","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R33-15-20210204","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/01.ico.0000134182.09569.e1","article-title":"Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols.","volume":"24","author":"Herrygers","year":"2005","journal-title":"Cornea"},{"key":"R34-15-20210204","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1185\/030079904X5959","article-title":"A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.","volume":"20","author":"Donnenfeld","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"Suppl","key":"R35-15-20210204","first-page":"4937","article-title":"Objective and subjective measurement of drug toxicity.","volume":"45","author":"Nguyen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl","key":"R36-15-20210204","first-page":"4936","article-title":"A comparative study in a normal pediatric population of the relative comfort of moxifloxacin 0.5% ophthalmic solution versus a tear substitute.","volume":"45","author":"Wagner","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-200809000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:01:27Z","timestamp":1786035687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-200809000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31816f27ab","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}